A stable turnover

but a 10% growth on signatures!

Monthly production 2015 & 2016

Full of great things

and a bad piece of news : London

Full of great things

International great things

  • Growth of 18%
  • Represents 1 third of our turnover
  • We run business from 8 countries
  • Alcimed sells in 16 countries
  • Big performance for Cologne (+23%) and Brussels (+49%)

Great things on clients' side

  • Prestigious new clients : Decathlon, Michelin, Naturex, SNCF, Veolia, Chiesi, IBA, Liebherr Aerospace, Moderna...
  • Stars among our clients : Moderna, Gilead, DBV, Naturex, Air Liquide...
  • 4 key accounts > 600 k€ and 10 key accounts > 400k€
  • 35 master service agreements
  • The pharmaceutical Top 10 is ours, and 5 more to conquer in the Top 20
  • 17 clients among French CAC 40

TOP 10 pharma

CAC 40

Highly satisfied clients

  • Quality grade above 9/10 for 150 projects out of 320 projects
  • 50 projects graded 10/10

Great things about projects

90 investigated countries
  • 30 languages of exploration
  • 400 projects

Great things about projects

  • Access strategy in Africa for Bayer and Gilead
  • Business model transformation for Airbus, Merial, Total...
  • New vaccinal approach for Moderna and DBV
  • Strategic foresight for Minefi (French Ministry of Foreign Affairs), Syngenta, Limagrain, Arvalis, SEB...
  • Généthon's BP in gene therapy
  • Digital impact for Celgene, Bayer Cropscience, Airbus...
  • Redesign of the innovation strategy for Sagem, Naturex

Great things about Alcimed transformation

New trainings

Great things : rise of the Alcimed brand

  • 61 press release
  • 112 press interviews
  • 6 publications per week
  • around 10 000 CVs received

And 2017?

Our project

Explore and develop uncharted territories

Reach the 1000s, while learning and having fun each day

Made with Adobe Slate

Make your words and images move.

Get Slate

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.